Cancer Subtyping on AMU-LSCC benchmark leaderboard · SOTA2 Research

Cancer Subtyping on AMU-LSCC

91.3ACCPID-LRSC

Evaluation Results

Method	Links
PID-LRSC2026.02		91.3	95.9
MacNet2026.02		90.58	96.57
MacNet2026.02		90.58	96.57
ACMIL-MHA2026.02		85.51	92.19
ILRA-MIL2026.02		85.51	91.99
ACMIL-MHA2026.02		85.51	92.19
ACMIL-MHA2026.02		84.06	91.31
RRT-MIL2026.02		83.33	90.57
TransMIL2026.02		82.61	90.21
MFC-MIL2026.02		82.61	91.26
MFC-MIL2026.02		82.61	90.67
TransMIL2026.02		82.61	90.21
MFC-MIL2026.02		82.61	91.26
DGR-MIL2026.02		81.88	91.47
TransMIL2026.02		81.88	91.59
S4MIL2026.02		81.88	90.65
DGR-MIL2026.02		81.88	90.6
DGR-MIL2026.02		81.88	91.47
S4MIL2026.02		79.71	88.45
S4MIL2026.02		79.71	88.45
RRT-MIL2026.02		76.81	87.32
CLAM-MB2026.02		76.81	85.56
RRT-MIL2026.02		76.81	87.32
IBMIL-DS2026.02		76.09	87.38
ABMIL2026.02		75.36	86.89
CLAM-SB2026.02		72.46	83.67
CLAM-SB2026.02		69.57	83.67
CLAM-SB2026.02		69.57	83.67
ILRA-MIL2026.02		68.84	80.48
ILRA-MIL2026.02		68.84	80.48
CLAM-MB2026.02		68.12	80.31
CLAM-MB2026.02		68.12	80.31
ABMIL2026.02		67.39	78.88
DTFD-MIL2026.02		67.39	81.38
ABMIL2026.02		67.39	78.88
IBMIL-DS2026.02		63.77	76.72
IBMIL-DS2026.02		63.77	76.72
FRMIL2026.02		63.77	80.2
DTFD-MIL2026.02		54.35	72.45
DTFD-MIL2026.02		54.35	72.45